Print Email

2018 MASCC/ISOO Annual Meeting Presentations

June 28-30, 2018  •  Vienna, Austria

WORKSHOPS >> See Workshops 2018 for descriptions and presentations.

PLENARY SESSIONS

Session 1: Cannabinoids for Symptom Management and Cancer Therapy
Therapeutic Applications of Cannabinoids in Oncology - Declan Walsh, USA
Do Cannabinoids Have a Role in the Management of Cancer Pain? - Paul Farquhar-Smith, United Kingdom
Established and Potential Therapeutic Applications of Cannabinoids in Oncology - Declan Walsh, USA

Session 2: Cardiac Toxicities Arising from Cancer Therapies
Ischemic Heart Disease in the Cancer Patient: Considerations Beyond Conventional Arteriosclerosis - Thomas Suter, Switzerland
Myocardial Inflammation after Check-Point Inhibitor Exposure: How Serious is the Problem? - Michael Ewer, USA
New Cardiac Guidelines – Where They Agree, Where They Differ, and How Does It Affect Patient Care - Sandra Swain, USA

Plenary Session 3: Post-Chemotherapy Cognitive Impairment
Cognitive Complaints in Survivors of Breast Cancer after Chemotherapy Compared with AGe-Matched Controls - Michelle Janelsins, USA
Assessing Cognitive Function in Adults Receiving Chemotherapy - Karin Olson, Canada
Overview of the Effects of Cancer Treatment on Cognitive Impairments in Children - Ida M (Ki) Moore, USA

PARALLEL SESSIONS

Session 02: Emergency Supportive Care
Validation of Clinical Index of Stabile Febrile Neutropenia (CISNE) Model: Can It Guide Emergency Physicians to a Reasonable Decision on Outpatient vs. Hospitalization? - Hae Moon, Republic of Korea
Incidence and Mortality of Spontaneous Intra-Cerebral Hemorrhage in Patients Presenting to the Emergency Department of a Comprehensive Cancer Center - Adriana Wechsler, USA
Emergency Medicine in Oncology: Background - Terry Rice, USA
Observation Units in Emergency Medical Oncology - Adam Klotz, USA
Evaluation of Immunotherapy Toxicity from the Emergency Standpoint - Tim Cooksley, United Kingdom

Session 03: Oral Care in Pediatric Oncology: Needs and Risks
Caring for the Long-Term Survivor of Pediatric Cancer: Dental and Oral Considerations - Cherry Estilo, USA
Risk Factors and Needs for Pediatric Cancer Patients with Mucositis - Wim Tissing, The Netherlands
Neutropenia and Oral Infection in Children with Cancer - Serap Karaman, Turkey
Decrease in Oral Care Utilization among Pediatric Cancer Survivors Is Mediated by Lower Education and Household Income - Derek Smith, USA
Prevalence of Patient-Reported Dysphagia and Oral Complications in Cancer Patients - Jacqui Frowen, Australia
Oral Late Effects and Taste Function in Long-Term Survivors after Treatment of Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumor During Childhood or Adolescence – Preliminary Results - Kristine Eidal Tanem, Norway

Session 04: Young Investigator Awards
The Association of Cancer-Related Fatigue with All-Cause Mortality of Colorectal and Endometrial Cancer Survivors: A Population-Based Study - Salome Adam, Switzerland
Cancer Care-Related Social Media and Internet Usage Differences between Age Groups among Patients with Cancer - Lawson Eng, Canada
The Effect of Prehabilitation on Preoperative Functional Capacity, Symptom Burden, and Postoperative Complications in Esophageal Cancer Surgery - Daisuke Makiura, Japan
Early Independent Prediction of Anthracycline-Induced Cardiomyopathy by N-Terminal Pro-Brain Natriuretic Peptide - Vladimir Poroch, Romania
Intravenous Fosaprepitant for the Prevention of Chemotherapy-Induced Vomiting in Children: A Randomized, Phase 3 Trial - Venkatraman Radhakrishnan, India
Photobiomodulation Therapy Prevents Severe Acute Radiodermatitis: A Randomized, Placebo-Controlled Trial in Breast Cancer Patients with Clinical and Objective Outcome Measures - Jolien Robijns, Belgium
Nasal Colonization with Staphylococcus Aureus Before Radiotherapy Predicts Radiation Dermatitis: A Prospective Study - Alexandra Rzepecki, USA
Protective Effect of Brain-Derived Neurotrophic Factor (BONF) Genetic Polymorphism (RS6265) against Chemotherapy-Related Cognitive Decline in Early-Stage Breast Cancer Patients: A Validation Study - Chia Jie Tan, Singapore
The Association between Glucocorticoid Receptor Sensitivity and Fatigue in Patients with Head and Neck Cancer - Canhua Xiao, USA
Leptin as a Predictive Biomarker for the Onset of Cancer-Related Fatigue: A Prospective Cohort Study - Toh Yi Long, Singapore

Session 05: Navigating the Twittersphere – How the Supportive Care Community Can Best Use Social Media to Further Our Health Intelligence
Twitter – What is the Evidence for Its Effectiveness? - Christopher Steer, Australia
This is How We Do It: A Social Media Toolkit for MASCC - Anna Boltong, Australia
Can Cancer Advocacy Be Influenced by Social Media? - Andreas Charalambous, Cyprus
Using a Symptom Heuristics iPad App to Improve Symptom Self-Management in Adolescents and Young Adults with Cancer - Suzanne Ameringer, USA
The Effect of a Culturally Tailored Internet Cancer Support Group on Supportive Care Needs of Asian and American Breast-Cancer Survivors - Eun-Ok Im, USA

Session 06: Challenges of Hemostasis in Cancer Patients
Eflapegrastim Is Safe and Effective in Reducing Severe Neutropenia in Patients Receiving Myelosuppressive Chemotherapy in a Phase 3 Randomized, Controlled Trial Compared to Pegfilgrastim (Advance) - Lee Schwartzberg, USA 
A Novel Approach to Improving Ambulatory Outpatient Management of Low-Risk Febrile Neutropenia: An Enhanced Supportive Care (ESC) Clinic - Tim Cooksley, United Kingdom 
Timing of Empirical Computerized Tomography Imagine of Chest in Children with High-Risk Febrile Neutropenia: Should Delayed Imaging Be Preferred? - Jaikumar Ramamoorthy, India 
Common Bleeding Disorders - Thein Hlaing Oo, USA 
VTE Risk Assessment - Cihan Ay, Austria 
Approach to VTE Recurrence - Isabelle Mahe, France 
Challenges of Vena Cava Filter - Simon Noble, United Kingdom

Session 07: How to Prevent Cardiotoxicity - A Real Challenge
Diagnosis of Cardiotoxicity in Children and How to Do Follow Up - Olga Salazar, USA 
Evidence of Infusion Duration of Anthracyclines, Does It Matter to the Heart? - Erik Loeffen, The Netherlands 
Evidence of Dexrazoxane and Other Interventions to Decrease Cardiotoxicity - Andrea Orsey, USA 
Systematic Review and Meta-Analysis: The Predictive Value of Serum Biomarkers in the Assessment and Management of Fever During Neutropenia in Children with Cancer - Tasnim Arif, United Kingdom 
Nutrition Support in a Paediatric Stem Cell Transplant Unit - Catherine Carroll, Ireland 
Is Usage of Colistimethate Sodium in Pediatric Oncology Practice Rational or Rampant? A Retrospective Self-Audit of a Tertiary Care Center - Jaikumar Ramamoorthy, India

Session 08: Cannabinoids for Symptom Management
Transforming Symptom Management in Cancer Patients: Is Medical Cannabis a New Paradigm? - Maria-Fernanda Arboleda, Canada
The Effect of Cannabis and Main Cannabinoids Use on Tumor Response to Nivolumab in Patients with Advanced Malignancies - Gil Bar-Sela, Israel
Cannabis-Based Medicines Show More Promise for Improving Appetite in Chronic Diseases - MariaLuisa Vigano, Canada
Cannabinoids in Taste and Flavor Function - Joel Epstein, USA
Cannabidiol in the Treatment of Chronic Neuropathic pain in Cancer Patients - Antonio Vigano, Canada
Cannabis Oil as an Adjunctive Treatment to Radiation Therapy in the Management of Cancer Pain - Jean A. Zigby, Canada

Session 09: JASCC/MASCC Joint Session - The Evolving Approach to Management of Cancer-Cachexia Syndrome
Molecular Mechanism of Cancer-Cachexia Syndrome - Jose Maria Argiles, Spain 
Overview of Clinical Trials and Practice on Cancer-Cachexia Syndrome - Liz Isenring, Australia 
Current Status Concerning Cancer-Cachexia Syndrome in Japan - Tateaki Naito, Japan

Session 10: Regimen-Related Oral Mucosal Injury - New Age Anti-Cancer Therapies
GC4419, Small Molecule Superoxide (SO) Dismutase (SOD) Mimetic: Randomized Trial to Reduce Chemoradiotherapy (CRT)-Induced Mucositis in Oral Cavity (OC)/Oropharyngeal (OP) Carcinoma (OCC) Patients - Carryn Anderson, USA 
Photobiomodulation Effects on Squamous Cell Carcinoma in an Orthotopic Animal Model of Squamous Cell Carcinoma of the Oral Cavity - Andrei Barasch, USA 
Personalized Supportive Care for Patients Receiving 5-Fluorouracil (5-FU): Interim Analysis of Multivariate SNP Risk Prediction for GI Toxicity - Samantha Korver, Australia 
Oral Mucositis Associated with Targeted Therapy and Immunotherapy - Nathaniel Treister, USA

Session 11: Education for a Better Chemotherapy Experience
The Necessary Information to Include in Pre-Chemotherapy Education: Nutrition, Medication, and Exercise to Improve Symptom Management and Survival - Judy Phillips, USA 
What is Accurate to Teach Patients and Families Regarding new Evidence on Medical Marijuana and E-Cigarettes? - Trevor Austin, USA 
Prevention and Educational Teaching for the Newly Diagnosed Oncology Patients, Regarding the Patient’s Risk of Blood Clot Development - Ellen Manzullo, USA 
How to Deal with the Psychological and Financial Issues Regarding the New Diagnosis of Cancer - Paz Fernández-Ortega, Spain 
Multimedia Psycho-education for Cancer Patients Eligible for Clinical Trials: A Randomized Clinical Trial - Charles Kamen, USA 
Supportive Care Starts with Communication and Collaboration: An Australian Perspective - Jodie Nixon, Australia 

Session 12: Chemotherapy-Induced Peripheral Neuropathy: 2018 Update
The Impact of Chemotherapy-Induced Peripheral Neuropathy in Australian Cancer Survivors: An Online Survey - Eva Battaglini, Australia
Cryocompression vs. Continuous-Flow Cooling: Optimal Method to Deliver Limb Hypothermia in Preventing Chemotherapy-Induced Peripheral Neuropathy - Aishwarya Bandla, Singapore
Long-Term Outcomes of Paclitaxel-Induced Peripheral Neuropathy for Cancer Survivors - Hannah Timmins, Australia
Gabapentinoid Use for Chemotherapy Neuropathy: The Good and the Bad - Charles Loprinzi, USA
Non-Drug Treatment Approaches For Chemotherapy Neuropathy - Maryam Lustberg, USA
Measuring CIPN in Practice and Research Settings - Ellen Lavoie Smith, USA

Session 13: Current and New Drugs to Maintain Bone Health: Oral Clinical Issues and Emerging Bone Health Issues in Cancer Patients
Occurrence of Skeletal-Related Events (SRES) in Patients with Solid Tumors and Bone Metastasis (ST/BM): Early Versus Late Initiation of SRE Preventative Agents (SPA) - Michele Intorcia, Switzerland
Characteristics of Osteonecrosis of the Jaw (MRONJ) in Cancer Patients Receiving Antiresorptive and/or Targeted Agents - Erofili Papadopoulou, Greece
To Do or Not to Do the Dental Extraction in Cancer Patients who Receive Bone-Targeted Agents (BTAS): A Systematic Review, BSG, MASCC, Part 1. - Emmanouil Vardas, Greece
Bone Targeting Agents: Current and New/Upcoming Drugs - Winston Tan, USA
Bone Health and Fractures: An Emerging Issue in Cancer Patients. From Chemotherapy to Targeted Therapies - Beatrice Edwards, USA

Session 14: Never Too Old - The Important Role of Exercise in Older Adults with Cancer
Supportive Care in Older Adults with Hematological Malignancie s - Reinhard Stauder, Austria 
Getting Fit for Transplant – The Role of Exercise in Older Adults with Haematological Malignancies - Thuy Koll, USA 
Malnutrition and Overall Survival in Older Patients with Cancer  - Beatrice Edwards, USA 
Preferences, Barriers, and Facilitators for Preoperative Exercise Participation for Elderly Treated for Colorectal Cancer and Their Social Network - Carla Agasi-Idenburg, The Netherlands 
The Impact of Falls on Cancer Treatment in Older Adults with Cancer - Schroder Sattar, Canada

Session 15: Educational Session: How to Write a Manuscript for Supportive Care in Cancer
Writing for Publication in Supportive Care in Cancer: Key Issues and Lessons Learned - Fred Ashbury, Canada
The Reviewer's View - Jørn Herrstedt, Denmark

Session 16: A “Good” Death – The Role of Supportive and Palliative Care
Introduction - A Good Death  - Andrew Davies, United Kingdom
Cancer Patients’ Experiences with an Early Palliative Care Conversation: A Qualitative Study of an Intervention Based on the SENS Structure - Monica Fliedner, Switzerland
Development and Initial Validation of a Prognostic Nomogram for Ambulatory Patients with Advanced Cancer - Carlos Paiva, Brazil
Does Palliative Care Improve End-of-Life Care? - Simon Noble, United Kingdom
Euthanasia: The European Experience - Luc Deliens, Belgium

Session 17: Dyspnea: Novel Strategies for Evaluation and Treatment
Dyspnea in Cancer Patients - Diwakar Balachandran, USA
Optimizing Respiratory Function in Cancer Patients: The Role of the Pulmonologist - Saadia Faiz, USA
Pro: Opioids Are Safe and Efficacious for the Management of Cancer-Related Dyspnea - David Hui, USA
Con: Pitfalls in the Use Opioids in the Palliation of Dyspnea - Mellar Davis, USA
Intensive Pulmonary Rehabilitation for Lung Cancer Patients: Is It Feasible? Is It Effective? - Vickie Shannon, USA
The Effect of Self-Efficacy-Enhancing-Based Active Cycle of Breathing Technique on Elder Lung Cancer Patients with Lung Resection - June Zhang, China

Session 18: SIOG/MASCC Joint Session - Supporting Older Adults with Cancer - Cognitive Impairment, Delirium and Sleep - A Practical Guide
Cognitive Impairment in Patients with Cancer – Overview - Beatrice Edwards, USA
Polypharmacy and Inappropriate Medication Use in Patients with Cognitive Impairment - Ting Ting Yeoh, Singapore
Sleep Disturbance in Older Adults with Cancer - Karin Olson, Canada
Practical Aspects of Managing Patients with Cognitive Impairment - Stephanie Dubruille, Belgium

Session 19: Recent Advances in the Management of Infections in Cancer Patients
Carboxymaltose in the Treatment of Chemotherapy-Induced Anemia: A Cost-Effectiveness and Cost-Minimization Analysis - Ana Joaquim, Portugal
Reducing Lead Time and Enhancing Quality of Infection management in a Cancer Center Urgent Care Clinic - Brenda Shelton, USA
Central Venous Catheter Infections among Adult Oncology Patients: A Retrospective, Single Irish Institution Experience - Jane Sze Yin Sui, Ireland
Febrile Neutropenia – Guidelines Update and Approach to Management of Both High- and Intermediate-Risk Patients - Bernardo Rapoport, South Africa
Principles for the Use of GCSFs for the Prevention and Management of Chemotherapy-Induced Neutropenia (CIN) - Jean Klastersky, Belgium
Prediction of Neutropenia and Febrile Neutropenia - Marianne Paesmans, Belgium

Session 20: Advances in Oncodermatology: Prevention and Management of Dermatologic Toxicities
Acute Moist Desquamation in Breast Cancer patients Treated with Hypofractionated vs. Conventional Radiotherapy: Preliminary Analysis - Sandrine Censabella, Belgium
Low-Level Laser Therapy in the Treatment of Chemotherapy- and Target Therapy-Induced Palmar-Plantar Erythrodysesthesia - Sofiya Latifyan, Belgium
Impact of Cancer Therapies on Hair and Management Strategies - Mario Lacouture, USA
Dermatologic Toxicities Associated with Immunotherapies and Management Strategies - Jennifer Choi, USA
Dermatologic Therapies for the Non-dermatologist - Kathryn Ciccolini Hernandez, USA

Session 21: Supporting Patients and Family Caregivers Throughout the Cancer Journey
Addressing Fear of Cancer Recurrence - Lidia Schapira, USA
Supporting Caregivers - Youngmee Kim, USA
Peer Support after Treatment with Curative Intent - Penelope Schofield, Australia
Top 10 Research Priorities for Teenage and Young Adult Cancer in the United Kingdom: Partnership between Young People, Carers and Professionals - Faith Gibson, United Kingdom
Explicit Prognostic Disclosure to Asian Women with Breast Cancer: A Randomized, Scripted Video-Vignette Study (J-Support 1601) - Masanori Mori, Japan
Understanding How Coping Strategies and Quality of Life Maintain Hope in Patients Deliberating Phase 1 Trial Participation - Diane van der Biessen, The Netherlands

Session 22: Side Effects of Targeted Drugs in Oncology
Off-Label Use of Statins for the Prevention of Radiation-Induced Normal Tissue Damage - Gerhard Fritz, Germany
Bayesian Analytics (BA) to Identify Relationships Between Cancer Treatment Regimens, Patient Comorbidities, and Specific Toxicity Risk: ToxScreen Care Demonstration Project - Gavin Ovsak, USA
Budesonide Reduces Neratinib-Induced Gastrointestinal Injury and Diarrhoea in Rats - Kate Secombe, Australia
Immunotherapies in Cancer: Promise and Burden - Rupert Bartsch, Austria
Benefit and Side Effect Profile of CDK4/6 Inhibitors - Christian Singer, Austria

Session 23: Managing Challenging Issues in Adolescent and Young Adult Cancer Survivors
Cognitive Impairment in AYA Cancer Survivors - Alex Chan, Singapore
Fertility Practices in AYA Cancer Survivors - Raymond Chan, Australia
Work after Cancer: Special Consideration in AYA Cancer Survivors - Bogda Koczwara, Australia
Prevalence of Prescription Psychoactive Medication Use in Adolescent Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study (CCSS) - Yin Ting Cheung, Hong Kong S.A.R.
Effect of Family-Oriented Rehabilitation on Quality of Life in Children with Brain Tumors and in Their Parents: Observational Prospective Study - Tatiana Nikitina, Russia
Adherence to the SCRF/AICR Recommendations for Cancer Prevention Is Associated with Better Health-Related Quality of Life among Colorectal Cancer Survivors - Merel van Veen, The Netherlands

Session 24: Developing Supportive Care in Eastern Europe: Different Models and Similar Challenges
Developing Supportive Care: Experience from Serbia - Snezana Bosnjak, Serbia
Supportive Care in Oncology in Eastern European Countries - Miroslav Tomiska, Czech Republic
Availability and Accessibility of Antiemetics in the Region: Barriers to Implementing MASCC/ESMO Guidelines - Jørn Herrstedt, Denmark
Assessment of Symptom Burden among Patients Diagnosed with Gastrointestinal (GI) Malignancies Admitted to Receive Chemotherapy at the Institute for Oncology and Radiology of Serbia (IORS) - Fedja Djordjevic, Serbia
Identifying Gaps in Immunotherapy Education Beyond the Oncology Team - Tara Perloff, USA
Availability of and Access to Antiemetics Needed for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) after HEC and Carboplatin in Serbia - Ana Zilic, Serbia

Session 25: Taste of San Francisco 2019
10 Reasons to Come to MASCC 2019 (San Francisco): Introduction to the Conference Theme of E-Health in Oncology - Andrew Davies, United Kingdom
How Technology Can Improve PROM - Ethan Basch, USA
iManageCancer – Results of a European R&D Project on Empowering Patients and Strengthening Self-Management in Cancer Diseases - Stephan Kiefer, Germany
Oral Microbiome and Oral Mucositis in Autologous Hematopoietic Stem Cell Transplantation Recipients - Alexa Laheij, The Netherlands
Understanding Physical Activity Behavior in Patients with Bladder Cancer before and after Radical Surgery: A Qualitative Interview Study - Elke Rammant, Belgium
Efficacy and Safety of Testosterone in Metastatic Renal Cell Carcinoma Patients with Fatigue: Multicenter Randomized Phase 2 Study (FARETES) - Ilya Tsimafeyeu, Russia

Session 26: The French Speaking Association for Supportive Care (AFSOS) Shares Its Guidelines
Introduction - Didier Kamioner, France
Highlights of AFSOS Meeting (October 12-14, 2017) - Ivan Krakowski, France
CINV and RINV: AFSOS Guidelines - Florian Scotté, France
Cancer and Thrombosis-Embolism: AFSOS Guidelines - Didier Mayeur, France
Patients Under Oral Anticancer Treatment, Therapeutic Education: AFSOS Guidelines - Typhaine Maupoint de Vandeul, France

ISOO

ISOO Session 01: Bone Necrosis: A Joint ASCO/MASCC/ISOO Consensus on Management and Prevention Strategies for the Oncologist and Dentist
From Dental Extractions to Drug Holidays: What Is the Evidence - Salvatore Ruggiero, USA
Osteoradionecrosis of the Jaw: Past and Present. Clinical and Economic Impact in Oncology - Jonn Wu, Canada
Does Prophylactic HBO Reduce the Incidence and Severity of ORN? Initial Results from a Multi-Centre Prospective Study - Allan Hovan, Canada

ISOO Session 02: Head and Neck Cancer-Related Pain: A Multidisciplinary Approach
Pain Syndromes in Head and Neck Cancer Patients - Barbara Murphy, USA
The Role of Nonsurgical Interventional Strategies for Head and Neck Cancer Related Pain - David Edwards, USA
Role of Surgery for Head and Neck Cancer-Related Pain - Hamid Shah, USA

ISOO Session 03: Diagnosis and Management of Oral Lesions Associated with Cancer Therapy: Separating the Good from the Bad and Ugly
Oro-Facial Conditions in Cancer Patients - Samson Ng, Canada
The Use of Noninvasive Optical and Molecular Tests in Management of an Oral Lesion - Catherine Poh, Canada
The Pitfalls in Diagnosis and Management of Oral Lesions in Cancer Patients - Siri Beier Jensen, Denmark

MASCC/ISOO Annual Meeting 2018 Closing Ceremony - Rajesh Lalla, USA

STUDY GROUP MEETINGS

Fatigue
A Longitudinal Assessment on the Impact of Higher Body Mass Index on Cancer-Related Fatigue in Breast Cancer Patients - Julia Inglis, USA
Cancer Related Fatigue (CRF): Perception of effort or task failure? - Carlos Fernandez, USA
Fatigue in the context of globalization: The social construction of symptom experience - Karin Olson, Canada

Geriatrics
Study Group Report - Christopher Steer

Hemostasis
Measurement of Adherence, Health-related Quality of Life, and Health-care Resource Utilization during Anticoagulation Therapy in Cancer-related Venous Thromboembolism - Cristhiam M. Rojas-Hernandez

Mucositis
Agenda and Overview - Sharon Elad

Nutrition and Cachexia Study Group
Agenda and Overview - Liz Isenring, Australia
Current Status Concerning Cancer-Cachexia Syndrome in Japan - Tateaki Naito, Japan
Cachexia - Egidio Del Fabbro, USA

Oral Care
Introduction/Agenda
Reproducibility in Systematic Reviews and Meta-Analyses - Derek Smith, USA
Development of Dysphagia Database and Proposed Items for Abstraction - Derek Smith, USA
Head and Neck Cancer and Sexuality:Patient priorities, preferences, and existing self-report measures - Kenneth Niermann, USA

Psychosocial
The Role of Cancer-Care Providers’ Empathy and Mindfulness in the Development of Burnout and Compassion Fatigue: An International Study - Penelope Schofield, Australia

Rehabilitation, Survivorship, and Quality of Life
Meeting Overview - Ray Chan, Australia
Malnutrition and Overall Survival in Older Cancer Patients - Xiaotao Zhang, USA
Prevalence of patient-reported dysphagia and oral complications in cancer patients - Jacqui Frowen, Australia

Skin Toxicity
Chill Update